Events2Join

Allergan Shareholders Approve Proposed Acquisition by AbbVie


Allergan Shareholders Approve Proposed Acquisition by AbbVie

Allergan plc (NYSE: AGN) (the "Company" or "Allergan") today announced that its shareholders have voted to approve the previously announced ...

Allergan Shareholders Approve Proposed Acquisition by AbbVie

AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion.

AbbVie Completes Transformative Acquisition of Allergan - May 8 ...

Under the terms of the transaction agreement, Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan ...

AbbVie Allergan Announcement

best interests of Allergan and the Allergan Shareholders, and thereby approved the Acquisition and determined that ... be proposed to the Allergan ...

Allergan Shareholders Overwhelmingly Approve Acquisition by ...

... shareholders have voted to approve the previously announced proposed acquisition of Allergan by AbbVie Inc. More than 99 percent of the ...

AbbVie Allergan Acquisition - Investor Presentation

Allergan shareholders are advised to read carefully the formal documentation in relation to the proposed Acquisition once the Scheme Documents ...

EX-99.1 - SEC.gov

Both meetings are being held to seek shareholder approval of the proposed Acquisition in accordance with Irish law. The approval of related matters by Allergan ...

Allergan (AGN) Shareholders Approve Acquisition by AbbVie

ABBV. Allergan said that approximately 68.6% of shareholders eligible to vote at Allergan's extraordinary general meeting of shareholders as ...

AbbVie to Acquire Allergan in Transformative Move for Both ...

Under the terms of the Transaction Agreement, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan ...

Concerning the Proposed Acquisition of Allergan plc by AbbVie Inc.

8 Nestlé Press Release, Nestlé to sell remaining Alcon shares to Novartis (Jan. ... In fact, the Nestlé Board had to approve the purchase here, ...

EX-99.1 - SEC.gov

Completion of the acquisition, which was announced on June 25, 2019, remains subject to the approval of Allergan shareholders and satisfaction of other ...

AbbVie Shareholders Will Get No Vote on Purchase of Allergan

Shareholders of the biopharmaceutical company AbbVie (ticker: ABBV) won't be allowed to vote on company's proposed $63 billion acquisition ...

AbbVie completes Allergan acquisition - Pf Media

Shareholders approved the proposed acquisition of Allergan by AbbVie in October 2019. ... shareholders will receive 0.8660 AbbVie shares ...

Abbvie to buy Allergan in $63bn deal - Financier Worldwide

Drug manufacturer Abbvie Inc is to acquire Irish rival Allergan Plc for around $63bn in a cash and stock transaction. The deal, which is subject to shareholder ...

FTC Imposes Conditions on AbbVie Inc.'s Acquisition of Allergan plc

Under the proposed consent agreement, AbbVie and Allergan are required to divest to Nestlé, S.A. Allergan's assets related to EPI drugs Zenpep ...

united states securities and exchange commission - form 8-k

AbbVie's proposed acquisition of Allergan (the “Acquisition”). As ... shareholders voted to approve the AbbVie Transaction. The AbbVie ...

Allergan Proxy Statement 101419 - AbbVie

approve an alternative acquisition proposal ... Allergan Superior Proposal, prior to the approval of the transaction by Allergan shareholders at ...

AbbVie Acquisition of Allergan: What does it mean for consumers ...

On June 25, 2019, consumers awoke to news that AbbVie plans to buy Allergan in a $63B deal, under which Allergan shareholders will receive 0.866 of one AbbVie ...

Allergan Shareholders Approve $63B Abbvie Acquisition

Allergan announced that shareholders approved the pending $63 billion acquisition by Abbvie, according to a press release Monday. The deal, ...

AbbVie News Center - News

All news · October 14, 2019. Allergan Shareholders Approve Proposed Acquisition by AbbVie · October 11, 2019. Allergan and Molecular Partners Present Late- ...